CASP2 and cancer: Understanding aneuploidy tolerance mechanisms more widely, and the BCL9L/caspase-2/BID axis specifically, may unravel potential vulnerabilities in aneuploid cancers, which could be exploited to limit intercellular heterogeneity, a substrate for selection and tumor evolution.